85R12889 LED-D     By: King of Hemphill, Kacal H.B. No. 3304       A BILL TO BE ENTITLED   AN ACT   relating to health benefit plan coverage for ovarian cancer testing   and screening.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 1370.003(b), Insurance Code, is amended   to read as follows:          (b)  Coverage required under this section includes at a   minimum:                (1)  a CA 125 blood test; [and]                (2)  a conventional Pap smear screening or a screening   using liquid-based cytology methods, as approved by the United   States Food and Drug Administration, alone or in combination with a   test approved by the United States Food and Drug Administration for   the detection of the human papillomavirus; and                (3)  any other test or screening approved by the United   States Food and Drug Administration for the detection of ovarian   cancer.          SECTION 2.  Section 1370.003, Insurance Code, as amended by   this Act, applies only to a health benefit plan delivered, issued   for delivery, or renewed on or after January 1, 2018. A health   benefit plan delivered, issued for delivery, or renewed before   January 1, 2018, is governed by the law as it existed immediately   before the effective date of this Act, and that law is continued in   effect for that purpose.          SECTION 3.  This Act takes effect September 1, 2017.